51. Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS Trial. (25th February 2022) Authors: Truong, Tien M.; Apfelbaum, Jeffrey L.; Danahey, Keith; Schierer, Emily; Ludwig, Jenna; George, David; House, Larry; Karrison, Theodore; Shahul, Sajid; Anitescu, Magdalena; Choksi, Anish; Hartman, Seth; Knoebel, Randall W.; van Wijk, Xander M. R.; Yeo, Kiang-Teck J.; Meltzer, David O.; Ratain, Ma... Journal: Anesthesia & analgesia Issue: Volume 135:Number 5(2022) Page Start: 929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
52. Prolonged Pharmacokinetic Interaction Between Capecitabine and a CYP2C9 Substrate, Celecoxib. (5th July 2019) Authors: Ramírez, Jacqueline; House, Larry K.; Karrison, Theodore G.; Janisch, Linda A.; Turcich, Michelle; Salgia, Ravi; Ratain, Mark J.; Sharma, Manish R. Journal: Journal of clinical pharmacology Issue: Volume 59:Number 12(2019) Page Start: 1632 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
53. Subcutaneous Atezolizumab: A Jab Without a Benefit. Issue 1 (23rd December 2021) Authors: Peer, Cody J.; Zimmerman, Sara M.; Figg, William D.; Goldstein, Daniel A.; Ratain, Mark J. Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 1(2022) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
54. The development of a financial toxicity patient‐reported outcome in cancer: The COST measure. Issue 20 (20th June 2014) Authors: de Souza, Jonas A.; Yap, Bonnie J.; Hlubocky, Fay J.; Wroblewski, Kristen; Ratain, Mark J.; Cella, David; Daugherty, Christopher K. Journal: Cancer Issue: Volume 120:Issue 20(2014) Page Start: 3245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
55. The development of a financial toxicity patient‐reported outcome in cancer: The COST measure. Issue 20 (20th June 2014) Authors: de Souza, Jonas A.; Yap, Bonnie J.; Hlubocky, Fay J.; Wroblewski, Kristen; Ratain, Mark J.; Cella, David; Daugherty, Christopher K. Journal: Cancer Issue: Volume 120:Issue 20(2014) Page Start: 3245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
56. The ImPreSS Trial: Implementation of Point‐of‐Care Pharmacogenomic Decision Support in Perioperative Care. Issue 6 (21st August 2019) Authors: Truong, Tien M.; Apfelbaum, Jeffrey; Shahul, Sajid; Anitescu, Magdalena; Danahey, Keith; Knoebel, Randall W.; Liebovitz, David; Karrison, Theodore; van Wijk, Xander M.R.; Yeo, Kiang‐Teck J.; Meltzer, David; Ratain, Mark J.; O'Donnell, Peter H. Journal: Clinical pharmacology & therapeutics Issue: Volume 106:Issue 6(2019) Page Start: 1179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
57. Two polymorphic gene loci associated with treprostinil dose in pulmonary arterial hypertension. Issue 4 (7th April 2022) Authors: Thomeas-McEwing, Vasiliki; Psotka, Mitchell A.; Gamazon, Eric R.; Friedman, Paula; Konkashbaev, Anuar; Kubo, Michiaki; Nakamura, Yusuke; Ratain, Mark J.; Benza, Raymond L.; Cox, Nancy J.; Gomberg-Maitland, Mardi I.; Maitland, Michael L. Journal: Pharmaocogenetics and genomics Issue: Volume 32:Issue 4(2022) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
58. Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance). (November 2014) Authors: Wang, Xiaofeng; Owzar, Kouros; Gupta, Pankaj; Larson, Richard A.; Mulkey, Flora; Miller, Antonius A.; Lewis, Lionel D.; Hurd, David; Vij, Ravi; Ratain, Mark J.; Murry, Daryl J.; Alliance for Clinical Trials in Oncology Journal: British journal of clinical pharmacology Issue: Volume 78:Number 5(2014:Nov.) Page Start: 1005 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
59. Vemurafenib oral bioavailability: An insoluble problem. (21st February 2014) Authors: Szmulewitz, Russell Z.; Ratain, Mark J. Journal: Journal of clinical pharmacology Issue: Volume 54:Number 4(2014:Apr.) Page Start: 375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗